[Assessment and follow up of diabetic patients in hemodialysis].
BACKGROUND
Despite a better management of the variables that influence the development of diabetic nephropathy there is a progressive increase in the prevalence of terminal renal failure among diabetics, whose cause is not clear.


OBJECTIVE
To study in a group of patients in hemodialysis, the quality of diabetes control previous to the entry to dialysis, their physical condition and their evolution.


METHODS
Diabetic patients with at least three months of hemodialysis answered a questionnaire about diabetes control quality previous to dialysis and had physical and laboratory assessment. They were followed for at least four years thereafter.


RESULTS
Fifty seven patients aged 62+/-11 years were studied. Eighty four percent had some degree of disability. Eighty seven percent had high blood pressure and 73% had to enter dialysis as an emergency. Mean glycosilated hemoglobin was 7.7% and 58% had a dialysis dose with a Kt/Vofless than 1.2. Fifty eight percent died during follow up. No relationship between mortality and age, blood pressure, glycosilated hemoglobin of Kt/V, was observed.


CONCLUSIONS
There is an inadequate management of blood glucose and blood pressure of diabetic patients before entry to dialysis. They are referred inverted exclamation markate to the nephrologist, the dialysis dose is insufficient and they have a high mortality.
Sanhueza
María Eugenia
ME
Nefrología, Departamento de Medicina, Hospital Clínico Universidad de Chile, Santiago, Chile. hemofiltracion@yahoo.es
Cotera
Alejandro
A
Elgueta
Leticia
L
López S
Gloria
G
Loncon
Patricia
P
Macan
Fernando
F
Pérez
Francisco
F
Cavada
Gabriel
G
Alvo
Miriam
M
D001786:Blood Glucose / Q000032:analysis*; D002677:Chile / Q000453:epidemiology; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D003928:Diabetic Nephropathies / Q000097:blood / Q000401:mortality / Q000628:therapy*; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000401:mortality / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000401:mortality; D016896:Treatment Outcome
D001786:Blood Glucose; D006442:Glycated Hemoglobin